Petein M - Search Results

1

High serum galectin-3 in advanced melanoma: preliminary results.

Vereecken P, Zouaoui Boudjeltia K, Debray C, Awada A, Legssyer I, Sales F, Petein M, Vanhaeverbeek M, Ghanem G, Heenen M. Vereecken P, et al. Among authors: petein m. Clin Exp Dermatol. 2006 Jan;31(1):105-9. doi: 10.1111/j.1365-2230.2005.01992.x. Clin Exp Dermatol. 2006. PMID: 16309497

2

Evaluation of extensive initial staging procedure in intermediate/high-risk melanoma patients.

Vereecken P, Laporte M, Petein M, Steels E, Heenen M. Vereecken P, et al. Among authors: petein m. J Eur Acad Dermatol Venereol. 2005 Jan;19(1):66-73. doi: 10.1111/j.1468-3083.2004.01130.x. J Eur Acad Dermatol Venereol. 2005. PMID: 15649194

3

Expression of galectin-3 in primary and metastatic melanoma: immunohistochemical studies on human lesions and nude mice xenograft tumors.

Vereecken P, Debray C, Petein M, Awada A, Lalmand MC, Laporte M, Van Den Heule B, Verhest A, Pochet R, Heenen M. Vereecken P, et al. Among authors: petein m. Arch Dermatol Res. 2005 Feb;296(8):353-8. doi: 10.1007/s00403-004-0536-6. Epub 2005 Jan 11. Arch Dermatol Res. 2005. PMID: 15645276

4

Spread of melanoma after lymphatic drainage: relaunching the debate.

Vereecken P, Mathieu A, Laporte M, Petein M, Heenen M. Vereecken P, et al. Among authors: petein m. Int J Clin Pract. 2003 Jun;57(5):444-5. Int J Clin Pract. 2003. PMID: 12846356

5

Decreased immunoreactive maspin expression in intermediate thickness and thick primary melanoma lesions.

Vereecken P, Reynaert S, Lalmand MC, Zouaoui-Boudjeltia K, Heenen M, Van Den Heule B, Petein M. Vereecken P, et al. Among authors: petein m. J Int Med Res. 2006 Jan-Feb;34(1):52-7. doi: 10.1177/147323000603400106. J Int Med Res. 2006. PMID: 16604823 Free article.

6

Colorimetric analysis of pigmented skin lesions: a pilot study with the Visi-Chroma VC-100 device.

Vereecken P, Mommaerts M, Duez C, Petein M, Laporte M, Hubinon JL, Heenen M. Vereecken P, et al. Among authors: petein m. J Eur Acad Dermatol Venereol. 2006 Jan;20(1):34-8. doi: 10.1111/j.1468-3083.2005.01334.x. J Eur Acad Dermatol Venereol. 2006. PMID: 16405605

7

Skin biopsies in DC vaccines for stage III-IV melanoma patients: role of neutrophils?

Laporte M, Trakatelli M, Vereecken P, Blocklet D, Lespagnard M, Petein M, Goldman M, Velu T, Heenen M. Laporte M, et al. Among authors: petein m. Arch Dermatol Res. 2007 Dec;299(10):483-6. doi: 10.1007/s00403-007-0786-1. Epub 2007 Oct 13. Arch Dermatol Res. 2007. PMID: 17934742 Clinical Trial.

8

Management of cutaneous locoregional recurrences of melanoma: a new therapeutic perspective with imiquimod.

Vereecken P, Mathieu A, Laporte M, Petein M, Velu T, Awada A, Heenen M. Vereecken P, et al. Among authors: petein m. Dermatology. 2003;206(3):279-80. doi: 10.1159/000068901. Dermatology. 2003. PMID: 12673091 No abstract available.

9

[Interest of immunohistochemic markers (Ki67, HMB45, p53) in risk analysis of congenital naevi of little and middle size].

Lejeune C, Laporte M, Musette S, Petein M, Heenen M. Lejeune C, et al. Among authors: petein m. Rev Med Brux. 2009 Sep-Oct;30(5):477-82. Rev Med Brux. 2009. PMID: 19998792 Review. French.

10

Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome.

Vereecken P, Monsieur E, Petein M, Heenen M. Vereecken P, et al. Among authors: petein m. J Dermatolog Treat. 2004 Apr;15(2):120-1. doi: 10.1080/09546630310017825. J Dermatolog Treat. 2004. PMID: 15204165 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters